Leyi Biology

Leyi Biology is a biotechnology startup founded in 2016 that has garnered significant attention for its groundbreaking work in breath molecular diagnostic technology. The company's slogan, "Pioneering swift digestive diagnoses through advanced breath molecular technology," encapsulates its mission to revolutionize digestive system diagnosis. Leyi Biology's research and innovation have led to the development of technology that enables rapid diagnosis for the digestive system by detecting specific markers in human breath. In its most recent funding round in 06 September 2023, Leyi Biology successfully secured an Angel Round investment from Thunderstorm VC and Hangzhou Yuhang Financial. This investment not only signals the market's faith in the startup's potential but also provides the necessary resources for Leyi Biology to further its research and innovation in the biotechnology space. With its strategic focus and innovative approach, Leyi Biology is positioned to make a meaningful impact in the field of biotechnology, specifically in the realm of digestive system diagnostics. The recent investment and partnerships with notable investors reflect confidence in the company's vision and potential, solidifying its status as a key player in the biotechnology industry.